242 related articles for article (PubMed ID: 36516487)
1. Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review.
Lehner KR; Jiang K; Rincon-Torroella J; Perera R; Bettegowda C
Neoplasia; 2023 Jan; 35():100852. PubMed ID: 36516487
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data.
Mirian C; Thastrup M; Mathiasen R; Schmiegelow K; Olsen JV; Østergaard O
Fluids Barriers CNS; 2024 Feb; 21(1):14. PubMed ID: 38350915
[TBL] [Abstract][Full Text] [Related]
3. The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors.
Mattox AK; Yan H; Bettegowda C
Neuro Oncol; 2019 Dec; 21(12):1509-1518. PubMed ID: 31595305
[TBL] [Abstract][Full Text] [Related]
4. Current Role and Future Potential of CSF ctDNA for the Diagnosis and Clinical Management of Pediatric Central Nervous System Tumors.
Miller AM; Karajannis MA
J Natl Compr Canc Netw; 2022 Dec; 20(12):1363-1369. PubMed ID: 36509077
[TBL] [Abstract][Full Text] [Related]
5. Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical Application.
Mikolajewicz N; Yee PP; Bhanja D; Trifoi M; Miller AM; Metellus P; Bagley SJ; Balaj L; de Macedo Filho LJM; Zacharia BE; Aregawi D; Glantz M; Weller M; Ahluwalia MS; Kislinger T; Mansouri A
J Clin Oncol; 2024 Jun; 42(16):1961-1974. PubMed ID: 38608213
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analyses of CSF aimed at biomarker development for pediatric brain tumors.
Samuel N; Remke M; Rutka JT; Raught B; Malkin D
J Neurooncol; 2014 Jun; 118(2):225-238. PubMed ID: 24771250
[TBL] [Abstract][Full Text] [Related]
7. The Utility of Liquid Biopsy in Central Nervous System Malignancies.
Nevel KS; Wilcox JA; Robell LJ; Umemura Y
Curr Oncol Rep; 2018 Jun; 20(8):60. PubMed ID: 29876874
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid circulating tumour DNA as a liquid biopsy for central nervous system malignancies.
Escudero L; Martínez-Ricarte F; Seoane J
Curr Opin Neurol; 2020 Dec; 33(6):736-741. PubMed ID: 33177377
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
Kopkova A; Sana J; Fadrus P; Slaby O
Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy in CNS tumors: Current status & future perspectives.
Husain N; Husain A; Mishra S; Srivastava P
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas.
Valerius AR; Webb MJ; Hammad N; Sener U; Malani R
Curr Oncol Rep; 2024 Apr; 26(4):377-390. PubMed ID: 38488990
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system.
Verheul C; Kleijn A; Lamfers MLM
Handb Clin Neurol; 2017; 146():139-169. PubMed ID: 29110768
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry-based proteomic techniques to identify cerebrospinal fluid biomarkers for diagnosing suspected central nervous system infections. A systematic review.
Bharucha T; Gangadharan B; Kumar A; de Lamballerie X; Newton PN; Winterberg M; Dubot-Pérès A; Zitzmann N
J Infect; 2019 Nov; 79(5):407-418. PubMed ID: 31404562
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas.
Shen F; Zhang Y; Yao Y; Hua W; Zhang HS; Wu JS; Zhong P; Zhou LF
Neurosurg Rev; 2014 Jul; 37(3):367-80; discussion 380. PubMed ID: 24781189
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: a review for practicing neurosurgeons.
Bounajem MT; Karsy M; Jensen RL
Neurosurg Focus; 2020 Jan; 48(1):E8. PubMed ID: 31896088
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.
van Westrhenen A; Smidt LCA; Seute T; Nierkens S; Stork ACJ; Minnema MC; Snijders TJ
Br J Haematol; 2018 Aug; 182(3):384-403. PubMed ID: 29808930
[TBL] [Abstract][Full Text] [Related]
18. Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and β2-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma.
Maeyama M; Sasayama T; Tanaka K; Nakamizo S; Tanaka H; Nishihara M; Fujita Y; Sekiguchi K; Kohta M; Mizukawa K; Hirose T; Itoh T; Kohmura E
Cancer Med; 2020 Jun; 9(12):4114-4125. PubMed ID: 32314548
[TBL] [Abstract][Full Text] [Related]
19. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
Drusco A; Bottoni A; Laganà A; Acunzo M; Fassan M; Cascione L; Antenucci A; Kumchala P; Vicentini C; Gardiman MP; Alder H; Carosi MA; Ammirati M; Gherardi S; Luscrì M; Carapella C; Zanesi N; Croce CM
Oncotarget; 2015 Aug; 6(25):20829-39. PubMed ID: 26246487
[TBL] [Abstract][Full Text] [Related]
20. The Role of Liquid Biopsies in Pediatric Brain Tumors.
Tang K; Gardner S; Snuderl M
J Neuropathol Exp Neurol; 2020 Sep; 79(9):934-940. PubMed ID: 32766689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
